TRPS1

protein-coding

transcriptional repressor GATA binding 1, the group of Zinc fingers C2H2-type|GATA zinc finger domain containing

Gene summary

This gene encodes a transcription factor that represses GATA-regulated genes and binds to a dynein light chain protein. Binding of the encoded protein to the dynein light chain protein affects binding to GATA consensus sequences and suppresses its transcriptional activity. Defects in this gene are a cause of tricho-rhino-phalangeal syndrome (TRPS) types I-III. [provided by RefSeq, Jul 2008]

MANE transcript

NM_014112.5

Inheritance

AD

ClinVar variants

P:190U:397B:239

Top phenotype

Trichorhinophalangeal syndrome, type I; Trichorhinophalangeal syndrome, type III

gnomAD constraint

pLI —, LoF o/e 0.02

Max pathogenic AF

—

Genomic locus

chr8:115,408,496-115,809,673

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~401.2 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

trichorhinophalangeal syndrome type I or IIISUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0019176

Submitter: Orphanet

trichorhinophalangeal syndrome type IDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0008596

Submitter: G2P

trichorhinophalangeal syndrome type ISTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0008596

Submitter: PanelApp Australia

trichorhinophalangeal syndrome, type IIISTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0008597

Submitter: PanelApp Australia

trichorhinophalangeal syndrome, type IIISTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0008597

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Trichorhinophalangeal syndrome, type I; Trichorhinophalangeal syndrome, type IIIAD

Manifestation: Craniofacial; Musculoskeletal; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 5991804; 10615131; 11112658; 19419465; 19610100; 19758263; 20394624; 21740822; 22481165 ; 27133561Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to TRPS1 variants in ClinVar

25 Conditions Cataloged
Trichorhinophalangeal dysplasia type ITotal: 608
Trichorhinophalangeal syndrome, type IIITotal: 543
Inborn genetic diseasesTotal: 195
not providedTotal: 135
not specifiedTotal: 59
TRPS1-related disorderTotal: 46
MicrocephalyTotal: 3
Trichorhinophalangeal syndromeTotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_014112.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
143
clinvar
12
clinvar
158
missense
6
clinvar
17
clinvar
378
clinvar
82
clinvar
2
clinvar
485
nonsense
49
clinvar
11
clinvar
3
clinvar
63
start loss
0
frameshift
73
clinvar
23
clinvar
12
clinvar
108
splice donor/acceptor (+/-2bp)
2
clinvar
9
clinvar
1
clinvar
12
Total1306039722514826

Highest pathogenic variant AF is 0.0000065838854

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 22 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_014112.5RefSeqNP_054831.26MANE Select
ENST00000395715.8EnsemblENSP00000379065.36MANE Select
NM_001282902.3RefSeqNP_001269831.16Standard
NM_001282903.3RefSeqNP_001269832.16Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • negative regulation of transcription by RNA polymerase II
  • skeletal system development
  • transcription by RNA polymerase II
  • NLS-bearing protein import into nucleus
  • regulation of chondrocyte differentiation

Molecular Function

  • RNA polymerase II regulatory region sequence-specific DNA binding
  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • DNA-binding transcription repressor activity, RNA polymerase II-specific
  • DNA-binding transcription factor activity
  • protein binding

Cellular Component

  • nuclear chromatin
  • nucleus
  • nucleoplasm
  • protein-containing complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000395715
Coding exons
6
Length
401176
Individuals with no LoFs
124686
Homozygous LoFs
0
Heterozygous LoFs
2
Defined
124688
p
0.00000802
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.545626750.8330.00003738551
Missense (PolyPhen)229342.130.669344372
Synonymous-0.6012832701.050.00001692490
Loss of Function5.92142.90.02330.00000234584

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.0000180.000018rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Transcriptional repressor. Binds specifically to GATA sequences and represses expression of GATA-regulated genes at selected sites and stages in vertebrate development. Regulates chondrocyte proliferation and differentiation. Executes multiple functions in proliferating chondrocytes, expanding the region of distal chondrocytes, activating proliferation in columnar cells and supporting the differentiation of columnar into hypertrophic chondrocytes. {ECO:0000269|PubMed:12885770, ECO:0000269|PubMed:17391059}.;
Disease
DISEASE: Tricho-rhino-phalangeal syndrome 1 (TRPS1) [MIM:190350]: Autosomal dominant disorder characterized by craniofacial and skeletal abnormalities. It is allelic with tricho-rhino-phalangeal type 3. Typical features include sparse scalp hair, a bulbous tip of the nose, protruding ears, a long flat philtrum and a thin upper vermilion border. Skeletal defects include cone-shaped epiphyses at the phalanges, hip malformations and short stature. {ECO:0000269|PubMed:14560312}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tricho-rhino-phalangeal syndrome 2 (TRPS2) [MIM:150230]: A syndrome that combines the clinical features of tricho-rhino- phalangeal syndrome type 1 and multiple exostoses type 1. Affected individuals manifest multiple dysmorphic facial features including large, laterally protruding ears, a bulbous nose, an elongated upper lip, as well as sparse scalp hair, winged scapulae, multiple cartilaginous exostoses, redundant skin, and mental retardation. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration resulting in the loss of functional copies of TRPS1 and EXT1 has been found in TRPS2 patients.; DISEASE: Tricho-rhino-phalangeal syndrome 3 (TRPS3) [MIM:190351]: Autosomal dominant disorder characterized by craniofacial and skeletal abnormalities. It is allelic with tricho-rhino-phalangeal type 1. In TRPS3 a more severe brachydactyly and growth retardation are observed. {ECO:0000269|PubMed:11112658, ECO:0000269|PubMed:11807863}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.134

Intolerance Scores

LoFtool
0.0223
RVIS EVS
-1.75
RVIS percentile EVS
2.36

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
S
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.257

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.